Former DOAR President Nicholas Croce dies
Long Island Business News Mon, 28 Mar 2011 14:02 PM PDT
After a short battle with a rare form of cancer, Nicholas Croce, the former president of Lynbrook-based DOAR Litigation Consulting and founder of Inference Data, died Sunday. A few months ago, Croce was diagnosed with Cholangiocarcinoma, a rare and slow-growing form of liver cancer that typically goes undetected. While most of the only 5,000 people who [...] |
White Shirt Campaign 2011
PR Newswire via Yahoo! Finance Mon, 28 Mar 2011 14:00 PM PDT
Today, Witchery has announced the launch of the 2011 White Shirt Campaign, with the aim of raising funds and awareness for the Ovarian Cancer Research Foundation . |
Researchers find many elderly men are undergoing unnecessary PSA screenings
PhysOrg Mon, 28 Mar 2011 13:55 PM PDT
A new study on the use of prostate-specific antigen (PSA)-based prostate cancer screening in the United States found that many elderly men may be undergoing unnecessary prostate cancer screenings. Using data from surveys conducted in 2000 and 2005, researchers report that nearly half of men in their seventies underwent PSA screening in the past year â€" almost double the screening rate of men in ... |
Radiation exposure: When is a little way too much?
Everett Herald Mon, 28 Mar 2011 13:55 PM PDT
As long as I live, I will never forget one question: Was she exposed to radiation as a child? No. Yes. I don't know. Each of those answers bombarded my guilt-ridden brain in the days and weeks after my daughter was diagnosed with papillary thyroid cancer. |
BMY's Cancer Drug Cleared in the US
Zacks.com via Yahoo! Finance Mon, 28 Mar 2011 13:50 PM PDT
The US Food and Drug Administration delivered a huge boost to Bristol-Myers Squibb Company by approving its cancer candidate ipilimumab. |
Interventional Radiology Y-90 Liver Cancer-Busting Treatment: Safe, Fast, Extends Life
redOrbit Mon, 28 Mar 2011 13:47 PM PDT
Multi-institutional study confirms previous findings: Treatment using yttrium-90 microspheres is safe, demonstrates anti-tumoral effect in patients where chemotherapy failed, preserves patient quality of life, extends lifeâ€"all done on an outpatient basis Interventional radiologists have been the leaders in the use of intra-arterial yttrium-90 radioembolization, since its introduction in 2000, to ... |
Some Women Worry Too Much About Breast Cancer Returning
redOrbit Mon, 28 Mar 2011 13:47 PM PDT
Latinas who speak little English, younger women most likely to express worry Most women face only a small risk of breast cancer coming back after they complete their treatment. Yet a new study from the University of Michigan Comprehensive Cancer Center finds that nearly half of Latinas who speak little English expressed a great deal of worry about recurrence. "Some worry about cancer recurrence ... |
Certain Breast Cancer Patients Worry Excessively About Recurrence
redOrbit Mon, 28 Mar 2011 13:47 PM PDT
A new study has found that certain types of women with early stage breast cancer are vulnerable to excessive worrying about cancer recurrence. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also indicates that worrying about cancer recurrence can compromise patients' medical care and quality of life. Thanks to recent medical advances, most ... |
| |
|